DOI QR코드

DOI QR Code

Determinants and burden of chronic kidney disease in a high-risk population in Korea: results from a cross-sectional study

  • Kang, Yong Un (Department of Internal Medicine, Chonnam National University Medical School) ;
  • Bae, Eun Hui (Department of Internal Medicine, Chonnam National University Medical School) ;
  • Ma, Seong Kwon (Department of Internal Medicine, Chonnam National University Medical School) ;
  • Kim, Soo Wan (Department of Internal Medicine, Chonnam National University Medical School)
  • Received : 2014.08.13
  • Accepted : 2015.06.25
  • Published : 2016.09.01

Abstract

Background/Aims: This study aimed to investigate the prevalence of chronic kidney disease (CKD) and associated risk factors in a high-risk population in Korea. Methods: A total of 6,045 participants aged ${\geq}65$ years (mean age, $73.0{\pm}5.5$) with diabetes or hypertension were enrolled. Participants were screened for CKD, which was defined as the presence of albuminuria (urine albumin-to-creatinine ratio ${\geq}30mg/g$) or an estimated glomerular filtration rate (eGFR) < $60mL/min/1.73m^2$. Results: The prevalence of CKD was 39.6% (women, 40.3%; men, 38.4%). Albuminuria was detected in 22.6% of participants, whereas eGFR < $60mL/min/1.73m^2$ was found in 24.6% of participants. The prevalence of CKD by stage was 4.4% for stage 1, 10.4% for stage 2, 23.4% for stage 3, 0.9% for stage 4, and 0.3% for stage 5. Older age, concomitant diabetes and hypertension, higher body mass index, higher systolic and diastolic blood pressure, and higher hemoglobin A1c levels were independently associated with the presence of CKD in multivariate-adjusted analyses that included with age, sex, body mass index, hypertension, diabetes, and smoking. Conclusions: The prevalence of CKD was very high in the present high-risk Korean population. Our results suggest that a screening method for early detection of CKD in high-risk populations is needed in Korea.

Keywords

Acknowledgement

Supported by : Chonnam National University Hospital Biomedical Research Institute, Korea Centers for Disease Control and Prevention, National Research Foundation of Korea (NRF)

References

  1. Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: approaches and initiatives: a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007;72:247-259. https://doi.org/10.1038/sj.ki.5002343
  2. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-2047. https://doi.org/10.1001/jama.298.17.2038
  3. Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005;16:180-188.
  4. de Jong PE, van der Velde M, Gansevoort RT, Zoccali C. Screening for chronic kidney disease: where does Europe go? Clin J Am Soc Nephrol 2008;3:616-623. https://doi.org/10.2215/CJN.04381007
  5. Imai E, Horio M, Watanabe T, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 2009;13:621-630. https://doi.org/10.1007/s10157-009-0199-x
  6. Chen N, Wang W, Huang Y, et al. Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant 2009;24:2117-2123. https://doi.org/10.1093/ndt/gfn767
  7. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-1305. https://doi.org/10.1056/NEJMoa041031
  8. Fried LF, Katz R, Sarnak MJ, et al. Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol 2005;16:3728-3735. https://doi.org/10.1681/ASN.2005040384
  9. Hunsicker LG. The consequences and costs of chronic kidney disease before ESRD. J Am Soc Nephrol 2004;15:1363-1364. https://doi.org/10.1097/01.ASN.0000126069.68755.99
  10. Locatelli F, Vecchio LD, Pozzoni P. The importance of early detection of chronic kidney disease. Nephrol Dial Transplant 2002;17 Suppl 11:2-7.
  11. John R, Webb M, Young A, Stevens PE. Unreferred chronic kidney disease: a longitudinal study. Am J Kidney Dis 2004;43:825-835. https://doi.org/10.1053/j.ajkd.2003.12.046
  12. Yu M, Ryu DR, Kim SJ, Choi KB, Kang DH. Clinical implication of metabolic syndrome on chronic kidney disease depends on gender and menopausal status: results from the Korean National Health and Nutrition Examination Survey. Nephrol Dial Transplant 2010;25:469-477. https://doi.org/10.1093/ndt/gfp483
  13. Kim S, Lim CS, Han DC, et al. The prevalence of chronic kidney disease (CKD) and the associated factors to CKD in urban Korea: a population-based cross-sectional epidemiologic study. J Korean Med Sci 2009;24 Suppl:S11-S21. https://doi.org/10.3346/jkms.2009.24.S1.S11
  14. Korean Society of Nephrology, ESRD Registry Committee. Renal replacement therapy in Korea: Insan Memorial Dialysis Registry 2005. Korean J Nephrol 2006;25:S425-S457.
  15. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006
  16. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005;67:2089-2100. https://doi.org/10.1111/j.1523-1755.2005.00365.x
  17. Chudek J, Wieczorowska-Tobis K, Zejda J, et al. The prevalence of chronic kidney disease and its relation to socioeconomic conditions in an elderly Polish population: results from the national population-based study PolSenior. Nephrol Dial Transplant 2014;29:1073-1082. https://doi.org/10.1093/ndt/gft351
  18. Hallan SI, Dahl K, Oien CM, et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ 2006;333:1047. https://doi.org/10.1136/bmj.39001.657755.BE
  19. Chadban SJ, Briganti EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol 2003;14(7 Suppl 2):S131-S138. https://doi.org/10.1097/01.ASN.0000070152.11927.4A
  20. Lin MY, Chiu YW, Lee CH, et al. Factors associated with CKD in the elderly and nonelderly population. Clin J Am Soc Nephrol 2013;8:33-40. https://doi.org/10.2215/CJN.05600612
  21. Cases Amenos A, Gonzalez-Juanatey JR, Conthe Gutierrez P, et al. Prevalence of chronic kidney disease in patients with or at a high risk of cardiovascular disease. Rev Esp Cardiol 2010;63:225-228. https://doi.org/10.1016/S0300-8932(10)70041-5
  22. Levey AS, Coresh J. Chronic kidney disease. Lancet 2012;379:165-180. https://doi.org/10.1016/S0140-6736(11)60178-5
  23. Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA 2003;290:3101-3114. https://doi.org/10.1001/jama.290.23.3101
  24. Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 2006;69:375-382. https://doi.org/10.1038/sj.ki.5000058
  25. Pinto-Sietsma SJ, Mulder J, Janssen WM, Hillege HL, de Zeeuw D, de Jong PE. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 2000;133:585-591. https://doi.org/10.7326/0003-4819-133-8-200010170-00008
  26. Ejerblad E, Fored CM, Lindblad P, et al. Association between smoking and chronic renal failure in a nationwide population-based case-control study. J Am Soc Nephrol 2004;15:2178-2185. https://doi.org/10.1097/01.ASN.0000135048.35659.10
  27. Korean Centers for Disease Control & Prevention. The National Health and Nutrition Examination Surveys [Internet]. Cheongju: Korean Centers for Disease Control & Prevention, c2014 [cited 2014 Dec 17]. Available from: http://www.cdc.go.kr/CDC/contents/CdcKrContent-View.jsp?cid=60602&menuIds=HOME001-MNU1130-MNU1639-MNU1640-MNU1645.
  28. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 2004;291:844-850. https://doi.org/10.1001/jama.291.7.844
  29. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004;65:1870-1876. https://doi.org/10.1111/j.1523-1755.2004.00582.x
  30. Domrongkitchaiporn S, Sritara P, Kitiyakara C, et al. Risk factors for development of decreased kidney function in a Southeast Asian population: a 12-year cohort study. J Am Soc Nephrol 2005;16:791-799. https://doi.org/10.1681/ASN.2004030208
  31. Kuo HW, Tsai SS, Tiao MM, Yang CY. Epidemiological features of CKD in Taiwan. Am J Kidney Dis 2007;49:46-55. https://doi.org/10.1053/j.ajkd.2006.10.007
  32. Tripepi G, Jager KJ, Dekker FW, Wanner C, Zoccali C. Bias in clinical research. Kidney Int 2008;73:148-153. https://doi.org/10.1038/sj.ki.5002648

Cited by

  1. The relationship between vitamin D and estimated glomerular filtration rate and urine microalbumin/creatinine ratio in Korean adults vol.62, pp.1, 2016, https://doi.org/10.3164/jcbn.17-69
  2. Chronic kidney disease in patients at high risk of cardiovascular disease in the United Arab Emirates: A population-based study vol.13, pp.6, 2016, https://doi.org/10.1371/journal.pone.0199920
  3. Burden of chronic kidney disease on the African continent: a systematic review and meta-analysis vol.19, pp.1, 2016, https://doi.org/10.1186/s12882-018-0930-5
  4. Association between prediabetes (defined by HbA1 C , fasting plasma glucose, and impaired glucose tolerance) and the development of chronic kidney disease: a 9-year prospective cohort study vol.20, pp.1, 2019, https://doi.org/10.1186/s12882-019-1307-0
  5. The KNOW-CKD Study: What we have learned about chronic kidney diseases vol.39, pp.2, 2016, https://doi.org/10.23876/j.krcp.20.042
  6. The Risk of Nephropathy, Retinopathy, and Leg Amputation in Patients With Diabetes and Hypertension: A Nationwide, Population-Based Retrospective Cohort Study vol.12, pp.None, 2021, https://doi.org/10.3389/fendo.2021.756189